2016
DOI: 10.1002/cyto.a.22906
|View full text |Cite
|
Sign up to set email alerts
|

Wild immunology assessed by multidimensional mass cytometry

Abstract: A great part of our knowledge on mammalian immunology has been established in laboratory settings. The use of inbred mouse strains enabled controlled studies of immune cell and molecule functions in defined settings. These studies were usually performed in specific-pathogen free (SPF) environments providing standardized conditions. In contrast, mammalians including humans living in their natural habitat are continuously facing pathogen encounters throughout their life. The influences of environmental condition… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
33
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 29 publications
(35 citation statements)
references
References 27 publications
2
33
0
Order By: Relevance
“…Thus, as outlined earlier, the chosen biomarkers should reflect differences in numbers or function of certain immune cell subpopulations. However, it is known from many previous studies that those parameters do not only depend on the clinical or “disease” status of the patient, but may also differ and change according to age, gender, ethnicity, or environmental challenges . Thus, in order to define inflammatory alterations in a given patient, it will be important to create secured data repositories from patients, but also healthy individuals, with clearly defined parameters such as age, life style, ethnic background, or other confounding factors.…”
Section: Clinical Translation–what Challenges Remain?mentioning
confidence: 99%
“…Thus, as outlined earlier, the chosen biomarkers should reflect differences in numbers or function of certain immune cell subpopulations. However, it is known from many previous studies that those parameters do not only depend on the clinical or “disease” status of the patient, but may also differ and change according to age, gender, ethnicity, or environmental challenges . Thus, in order to define inflammatory alterations in a given patient, it will be important to create secured data repositories from patients, but also healthy individuals, with clearly defined parameters such as age, life style, ethnic background, or other confounding factors.…”
Section: Clinical Translation–what Challenges Remain?mentioning
confidence: 99%
“…Recently, awareness arose about the limitations of commonly used animal models regarding the shortcomings of clinical challenges (32,33). With increasing knowledge about the role of the adaptive immune system, in particular of tissue-resident and tissue-infiltrating T cells, in controlling challenged tissue homeostasis it is more evident than ever that our widely used SPF mouse models do not reflect the "aging" immune system as seen in adults (15,16).…”
Section: Discussionmentioning
confidence: 99%
“…Despite success in efficient translation of animal studies to the clinic, many murine models failed to translate promising treatments of disease models to clinical studies, as relevant aspects of the human immune system are unappreciated by SPF mice (13,14) . Recent studies claimed that murine models housed under standard SPF conditions lack effector/memory T cells in contrast to mice exposed to antigens, such as pet shop and free-living mice (15)(16)(17)(18).…”
Section: Introductionmentioning
confidence: 99%
“…These studies also highlight the diversity of individual immune profiles that will be encountered in a clinical vaccine-development program. The relative complexity of "experienced" immune systems was further demonstrated by comparative mass cytometry profiling of leukocytes from "clean" laboratory mice and pet shop mice (31). The comparatively naive immune system status of standard laboratory-reared, immune-competent mice merits consideration when designing and interpreting preclinical studies aimed at identifying candidate immuneresponse biomarkers for clinical application.…”
Section: Immune Profiling By Mass Cytometry In Vaccine Developmentmentioning
confidence: 99%